VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31 | +6.9% | 7,205 | +61.1% | 0.00% | – |
Q2 2023 | $29 | +61.1% | 4,473 | +68.8% | 0.00% | – |
Q1 2023 | $18 | +38.5% | 2,650 | +50.8% | 0.00% | – |
Q4 2022 | $13 | -98.7% | 1,757 | +1389.0% | 0.00% | – |
Q3 2022 | $1,000 | – | 118 | +187.8% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 41 | -50.0% | 0.00% | – |
Q1 2022 | $1,000 | -75.0% | 82 | -69.7% | 0.00% | – |
Q4 2021 | $4,000 | +300.0% | 271 | +561.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | – | 41 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |